BUD(BUD)
BUD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $64.43B | $66.89B | $69.51B | $74.67B | $77.26B |
| Low | $62.73B | $65.80B | $67.71B | $72.74B | $75.26B |
| High | $65.31B | $67.87B | $70.81B | $76.07B | $78.71B |
| EBITDA Avg | $24.46B | $25.39B | $26.38B | $28.34B | $29.33B |
| Low | $23.81B | $24.97B | $25.70B | $27.61B | $28.57B |
| High | $24.79B | $25.76B | $26.88B | $28.87B | $29.87B |
| EBIT Avg | $18.05B | $18.74B | $19.47B | $20.92B | $21.64B |
| Low | $17.57B | $18.43B | $18.97B | $20.38B | $21.08B |
| High | $18.30B | $19.01B | $19.83B | $21.31B | $22.05B |
| Net Income Avg | $8.72B | $9.68B | $10.65B | $12.05B | $14.46B |
| Low | $7.89B | $9.06B | $10.29B | $11.65B | $13.98B |
| High | $9.21B | $10.18B | $10.91B | $12.34B | $14.81B |
| EPS Avg | $4.40 | $4.88 | $5.37 | $6.07 | $7.29 |
| Low | $3.98 | $4.57 | $5.19 | $5.87 | $7.04 |
| High | $4.64 | $5.13 | $5.50 | $6.22 | $7.47 |
| Analysts (Rev / EPS) | 16 / 8 | 16 / 8 | 14 / 7 | 15 / 6 | 15 / 6 |
| Metric | Q4 2026 |
|---|---|
| Revenue Avg | $16.15B |
| Low | $15.77B |
| High | $16.37B |
| EBITDA Avg | $6.13B |
| Low | $5.99B |
| High | $6.21B |
| EBIT Avg | $4.52B |
| Low | $4.42B |
| High | $4.58B |
| Net Income Avg | $2.30B |
| Low | $2.20B |
| High | $2.39B |
| EPS Avg | $1.16 |
| Low | $1.11 |
| High | $1.21 |
| Analysts (Rev / EPS) | 6 / 3 |